CYP cynata therapeutics limited

Ann: Appendix 4D & Half-Year Financial Statements, page-58

  1. 2,282 Posts.
    lightbulb Created with Sketch. 1205
    I haven't done a thorough analysis of the cost of doing a phase 2 GvHD trial - had I, I'd not object to you critiquing it.

    You suggested you'd done some. I don't promise to critique it if you post it - it will likely depend on whether I consider it worth responding to - but if you don't then I definitely won't.

    Let's assume you aren't going to wound or amaze me with a witty off topic deflection and save it.

    I've paid you a compliment (I'm not fond of your posting style but I respect your intellect) and expressed an interest in hearing more of what you think about something you have been posting about repeatedly (the cost of a phase 2), so do as you wish now.

    Your usual conversant awaits you.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
0.005(3.23%)
Mkt cap ! $36.15M
Open High Low Value Volume
15.5¢ 16.0¢ 15.5¢ $4.604K 29.61K

Buyers (Bids)

No. Vol. Price($)
5 58900 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 15860 3
View Market Depth
Last trade - 10.37am 27/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.